These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8894517)

  • 21. Metabolism of a dopamine receptor partial agonist in rats, including an unusual N-dearylation reaction.
    Zhao SX; Wang WW; Walker GS; Zhang L; Obach RS
    Drug Metab Pharmacokinet; 2011 Jun; 26(3):266-79. PubMed ID: 21383524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
    Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of BVT.2938 metabolites by LC/MS and LC/MS/MS after in vitro incubations with liver microsomes and hepatocytes.
    Edlund PO; Baranczewski P
    J Pharm Biomed Anal; 2004 Mar; 34(5):1079-90. PubMed ID: 15019042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of the antipsychotic drug tiospirone in humans.
    Mayol RF; Jajoo HK; Klunk LJ; Blair IA
    Drug Metab Dispos; 1991; 19(2):394-9. PubMed ID: 1676643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro metabolism of ethoxidine by human CYP1A1 and rat microsomes: identification of metabolites by high-performance liquid chromatography combined with electrospray tandem mass spectrometry and accurate mass measurements by time-of-flight mass spectrometry.
    Deroussent A; Ré M; Hoellinger H; Vanquelef E; Duval O; Sonnier M; Cresteil T
    Rapid Commun Mass Spectrom; 2004; 18(4):474-82. PubMed ID: 14966856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry.
    Kim E; Kim H; Suh K; Kwon S; Lee G; Park NH; Hong J
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1183-95. PubMed ID: 23650031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
    Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
    Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry.
    Liu Z; Huang L; Dai M; Chen D; Tao Y; Wang Y; Yuan Z
    Rapid Commun Mass Spectrom; 2009 Jul; 23(13):2026-34. PubMed ID: 19504544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzymatic C-demethylation of 1-[2-(5-tert-butyl-[1,3,4] oxadiazole-2-carbonyl)-4-fluoro-pyrrolidin-1-yl]-2-(2-hydroxy-1,1-dimethyl-ethylamino)-ethanone (LC15-0133) in rat liver microsomes.
    Yoo HH; Chung HJ; Lee J; Lee CS; Kang MJ; Kim DH
    Drug Metab Dispos; 2008 Mar; 36(3):485-9. PubMed ID: 18057116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterases.
    Karanam BV; Hop CE; Liu DQ; Wallace M; Dean D; Satoh H; Komuro M; Awano K; Vincent SH
    Drug Metab Dispos; 2004 Sep; 32(9):1015-22. PubMed ID: 15319344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the metabolic activation of disulfiram in rat. Evidence for electrophilic S-oxygenated metabolites as inhibitors of aldehyde dehydrogenase and precursors of urinary N-acetylcysteine conjugates.
    Hu P; Jin L; Baillie TA
    J Pharmacol Exp Ther; 1997 May; 281(2):611-7. PubMed ID: 9152363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous measurement of metabolic stability and metabolite identification of 7-methoxymethylthiazolo[3,2-a]pyrimidin-5-one derivatives in human liver microsomes using liquid chromatography/ion-trap mass spectrometry.
    Kantharaj E; Ehmer PB; Tuytelaars A; Van Vlaslaer A; Mackie C; Gilissen RA
    Rapid Commun Mass Spectrom; 2005; 19(8):1069-74. PubMed ID: 15776495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
    Erve JC; Vashishtha SC; DeMaio W; Talaat RE
    Drug Metab Dispos; 2007 Jun; 35(6):908-16. PubMed ID: 17353349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo phase II metabolism of combretastatin A-4: evidence for the formation of a sulphate conjugate metabolite.
    Aprile S; Del Grosso E; Grosa G
    Xenobiotica; 2009 Feb; 39(2):148-61. PubMed ID: 19255941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation of tolterodine, a new muscarinic receptor antagonist, in mice, rats, and dogs.
    Andersson SH; Lindgren A; Postlind H
    Drug Metab Dispos; 1998 Jun; 26(6):528-35. PubMed ID: 9616187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
    Lang D; Freudenberger C; Weinz C
    Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.